Likewise, experimental colitis evoked by trinitrobenzene sulfonic acid in rodents is aggravated by the CGRP receptor antagonist CGRP8–37, a CGRP antibody (Reinshagen et al., 1998), and genetic deletion of CGRP (Engel et al., 2011). The gene discussed is CALCA; the disease is colitis.